In France, GE Healthcare Announces the First Global Installation of Its Discovery IGS 730 System for Hybrid Operating Rooms

  In France, GE Healthcare Announces the First Global Installation of Its
  Discovery IGS 730 System for Hybrid Operating Rooms

  *Discovery IGS 730 enables complex minimally-invasive endovascular and
    percutaneous procedures on inoperable patients
  *A ground-breaking interventional system that allows installation with
    minimal adaptation costs for the hospital
  *This mobile imaging system is the last stage of a 32 million Euros
    investment by GE Healthcare France and the result of 150 researcher’s
  *A global première installed in France (Lille), before going to the United
    States (Pennsylvania) and soon to Asia

Business Wire

BUC, France -- December 11, 2012

GE Healthcare announces the first global installation in France of the
Discovery IGS 730 system for hybrid Operating Rooms and imaging departments.
It will allow performing complex minimally-invasive endovascular and
percutaneous procedures on inoperable patients suffering from cardiovascular
pathologies such as ruptured aorta aneurysms, fainting spells or
cerebrovascular accidents. “The Discovery IGS 730 is a true innovation
allowing us to conduct complex minimally invasive hybrid procedures in a
secure setting. With this technology we are treating “high risk” patients
unfit for open surgery. In a year, this technology will allow us to perform
500 complex aortic repairs in such patients. The majority of patients will
have a reduced hospital stay and a quick return to normal activity. In
addition, in terms of mobility/patient access and the ergonomics of the
operating room, this is a huge step forward”, said Prof. Haulon, Head of
Vascular Surgery Department, University Hospital of Lille, France.

World's first installation and clinical use of GE Healthcare’s Discovery IGS
730 at the Lille Univer ...

World's first installation and clinical use of GE Healthcare’s Discovery IGS
730 at the Lille University Hospital in France.

A major innovation developed and produced in France: Discovery IGS 730

The hybrid operating room allows both open surgery and catheter-based imaging
therapies to take place in the same operating room. The hybrid OR enables
multiple physicians (surgeons, Interventionalist, nurses, anaesthesiologists,
and technicians) to perform a new spectrum of minimally invasive therapies
with the goal of ultimately enabling better patient care. These complex
minimally-invasive endovascular and percutaneous procedures will allow
discharging patients much faster (5 days in comparison to an average of 10
days) and reduce patient rehabilitation.

“In designing the Discovery IGS 730, it was always our goal to provide the
latest in interventional efficiency – with high precision imaging capability
and exceptional in-room mobility. This solution aims to accommodate a wide
range of minimally invasive and surgical procedures. Due to the technological
innovation and the advanced application portfolio available, we hope it will
allow our customers to explore and discover new ways within both the
Interventional and the Operating Room.” says Chantal Le Chat, General Manager,
Premium Angiography, GE Healthcare, Detection & Guidance Solutions.

The Discovery IGS 730 is a laser-guided, mobile gantry, a first-of-its kind in
interventional imaging. The system is neither floor nor ceiling mounted and
enables full patient access, creating an interventional environment without
boundaries. It has the mobility of a C-arm with the power and image quality of
a fixed system, allowing multiple parking possibilities, while helping
maintain sterility for a flexible and secure OR environment. It is intended
for oncology (hepatic and bone tumors), neurology (aneurysms and brain tumors)
as well as cardiovascular patients (stent appositions). Discovery IGS 730 is
the only x-ray angiographic medical imaging system with such mobility in the

Discovery IGS 730, the outcome of a 32 million Euros investment in France

In total, 12 international patents have been registered for this
ground-breaking technological innovation. Discovery IGS 730 has been developed
within the IRIMI project, a public-private partnership that involved several
French laboratories and partially funded by the French government (IRIMI

“With the installation of the Discovery IGS 730 in France, our R&D factory of
Buc (Parisian Region) has become the birthplace of a ground-breaking
innovation in worldwide surgery. With this, our 420 France-based researchers
have proven to be able to find technological innovations that allow new
treatments, reduce risks for the patients and provide solutions for health
professionals” declared Robert Sigal, CEO, GE Healthcare France.

About GE Healthcare

GE Healthcare provides transformational medical technologies and services that
are shaping a new age of patient care. Our broad expertise in medical imaging
and information technologies, medical diagnostics, patient monitoring systems,
drug discovery, biopharmaceutical manufacturing technologies, performance
improvement and performance solutions services help our customers to deliver
better care to more people around the world at a lower cost. In addition, we
partner with healthcare leaders, striving to leverage the global policy change
necessary to implement a successful shift to sustainable healthcare systems.
Our “healthymagination” vision for the future invites the world to join us on
our journey as we continuously develop innovations focused on increasing
access and improving quality and affordability around the world. Headquartered
in the United Kingdom, GE Healthcare is a unit of General Electric Company
(NYSE: GE). Worldwide, GE Healthcare employees are committed to serving
healthcare professionals and their patients in more than 100 countries. For
more information about GE Healthcare, visit our website at For our latest news, please visit

Photos/Multimedia Gallery Available:



GE Healthcare:
Pilar Anton Serrano
06 65 87 47 51
Press spacebar to pause and continue. Press esc to stop.